ClinicalTrials.gg
Not yet recruitingNCT07896161Updated Oct 26, 2026

Evaluation of a DRG-Based Clinical Management Model in a High-Complexity Chilean Hospital

An interventional study of Support medical decision making and Standard Care (in control arm) in Hospitalisation, sponsored by Pontificia Universidad Catolica de Chile. Not yet recruiting at 1 site in Chile. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Pontificia Universidad Catolica de Chile · Not applicable, Interventional, and Health services research

Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
1,167
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the effectiveness and scalability of a clinical management model based on the use of Diagnosis-Related Groups (DRGs) in a high-complexity hospital in Chile. A quasi-experimental design will be used, comparing efficiency and quality indicators between patients managed under the new DRG model versus usual care.

Read the detailed description

The intervention involves concurrent DRG coding from the patient's admission, integrating this information into the electronic medical record and visual dashboards for clinical and administrative teams. The model will allow teams to anticipate clinical trajectories, facilitate decision-making, and monitor key indicators in real-time. It is expected to demonstrate a significant reduction in the average length of stay without compromising the quality of care.

02

Conditions studied

  • Hospitalisation

Keywords

  • Interventional
  • Diagnosis-Related Groups (DRGs)
  • efficiency
03

In context

Lead sponsor

Pontificia Universidad Catolica de Chile is the lead sponsor of 224 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hospitalized adult patients admitted to any specialized clinical service (medical or surgical).
  • Patients managed by attending physicians and clinical teams who have implemented and are actively utilizing the DRG-based clinical management software (the intervention).
  • Cases corresponding to Diagnosis-Related Groups (DRGs) selected based on frequency or clinical relevance within the institution's case-mix.

Exclusion criteria

Exclusion Criteria:

  • Insufficient information in the clinical records
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,167 participants (estimated)

Study arms

  • Experimental
    Arm 1: Intervention Group (DRG Model)

    Hospitalized patients managed using clinical information dashboards and concurrent DRG coding

    Device: Support medical decision making

  • Placebo comparator
    Arm 2: Control Group (Usual Care)

    Hospitalized patients receiving standard care according to current hospital clinical protocols, extracted from anonymized databases.

    Other: Standard Care (in control arm)

Interventions

  • DeviceSupport medical decision making

    Implementation of a system displaying clinical trajectories and indicators to support medical decision-making without altering medical treatments, diagnoses, or clinical decision.

  • OtherStandard Care (in control arm)

    Hospitalized patients receiving standard care according to current clinical protocols at the institution. Data for this group will be extracted from anonymized electronic medical records and the Minimum Basic Data Set (MBDS). These patients will not be exposed to the concurrent DRG coding model or visual clinical dashboards. The extracted data will match the selected DRGs (Case-Mix) of the intervention group to compare outcomes such as average length of stay (LOS), readmission rates, and in-hospital mortality, adjusted for risk and severity

06

What researchers measure

Primary outcomes

  1. Clinical Efficiency - Average Length of Stay

    Measurement of the adjusted average length of hospital stay as a standardized efficiency indicator.

    Time frame: 12 months from the start of the DRG model

Secondary outcomes

  1. Quality of Care (Clinical Audit)

    Evaluation based on structured guidelines designed to evaluate compliance with quality standards for the most frequent DRGs, with standardized scores from 0 to 100

    Time frame: 12 months from the start of the DRG model

  2. Adverse Events and Infections

    Rate of healthcare-associated infections and recorded adverse events

    Time frame: 12 months from the start of the DRG model

  3. Readmissions and Mortality

    Rate of related readmissions and in-hospital mortality.

    Time frame: 12 months from the start of the DRG model.

  4. Usability

    Participating clinical care teams will be invited to complete the System Usability Scale (SUS) survey to evaluate the usability of computer systems (software, applications, web platforms). Specifically, the SUS scale consists of 10 statements rated on a 1-to-5 Likert scale. Scores are expressed on a scale of 0 to 100, with 68 considered the minimum threshold for positive usability.

    Time frame: 12 months from the start of the DRG model

  5. Experience and acceptance

    Semi-structured interviews will be conducted to explore the experiences, perceptions, and acceptance of clinical and administrative teams regarding the implementation of the DRG-based clinical management model. The goal of these interviews is to: Understand how clinical and administrative staff perceive the usefulness and applicability of the model in their daily practice. Identify facilitators and barriers to its effective implementation (e.g., availability of time, patient load, institutional support, ease of use of the system). Evaluate the integration of the model into clinical and administrative decision-making-that is, whether DRG information is perceived as a potential contributor to improving efficiency or quality.

    Time frame: 12 months from the start of the DRG model

07

Study locations

1 site
  • Pontificia Universidad Católica de Chie
    Santiago, Chile
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for May 2027, 8 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 19, 2026
First posted
Oct 26, 2026
StartEst.
Sep 2026
Primary completionEst.
May 2027
CompletionEst.
Dec 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07896161
Responsible party
Fernando Poblete Arrué (Principal Investigator and Assistant Professor, Pontificia Universidad Catolica de Chile) — Principal investigator
First posted
Oct 26, 2026
Start date
Sep 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Oct 26, 2026

Study contacts

Fernando Poblete, MD
Contact
fcpoblete@gmail.com
+56 9 91398760

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion